[(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid

C63H104FN3O22S — CID 172945734

IUPAC[(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid
SMILESCO/N=C1\C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3CC(C)N(C)C[C@H](C)O3)[C@@H](C)C(=O)O[C@H]([C@@H](C)CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@H](C)[C@@H](OC(=O)CC(C)C)[C@@H](C)C(=O)[C@@](C)(OC(=O)NC(C)(C)CCS(=O)(=O)c3ccccc3F)C[C@@H]2C)[C@@H]1O.O=CO
InChIInChI=1S/C62H102FN3O20S.CH2O2/c1-32(2)26-46(67)82-52-39(9)51(34(4)31-78-59-55(76-18)54(75-17)48(68)42(12)81-59)84-57(71)41(11)53(83-47-27-35(5)66(16)30-37(7)79-47)38(8)50(85-58-49(69)44(65-77-19)28-36(6)80-58)33(3)29-62(15,56(70)40(52)10)86-60(72)64-61(13,14)24-25-87(73,74)45-23-21-20-22-43(45)63;2-1-3/h20-23,32-42,47-55,58-59,68-69H,24-31H2,1-19H3,(H,64,72);1H,(H,2,3)/b65-44+;/t33-,34-,35?,36+,37-,38+,39-,40+,41+,42+,47-,48+,49+,50-,51+,52+,53-,54+,55+,58-,59+,62-;/m0./s1
InChIKeyURUFOIQOFMYMDO-HVPQTUPFSA-N
MW1306.59 g/mol
LogP6.49
Rot. Bonds20

About [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid

[(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid (PubChem CID 172945734) has the molecular formula C63H104FN3O22S and a molecular weight of 1306.59 g/mol. Its IUPAC name is [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid.

Molecular Properties

Compound Name[(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid
PubChem CID172945734
Molecular FormulaC63H104FN3O22S
Molecular Weight1306.59 g/mol
Exact Mass1305.68
IUPAC Name[(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid
SMILESCO/N=C1\C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3CC(C)N(C)C[C@H](C)O3)[C@@H](C)C(=O)O[C@H]([C@@H](C)CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@H](C)[C@@H](OC(=O)CC(C)C)[C@@H](C)C(=O)[C@@](C)(OC(=O)NC(C)(C)CCS(=O)(=O)c3ccccc3F)C[C@@H]2C)[C@@H]1O.O=CO
InChIInChI=1S/C62H102FN3O20S.CH2O2/c1-32(2)26-46(67)82-52-39(9)51(34(4)31-78-59-55(76-18)54(75-17)48(68)42(12)81-59)84-57(71)41(11)53(83-47-27-35(5)66(16)30-37(7)79-47)38(8)50(85-58-49(69)44(65-77-19)28-36(6)80-58)33(3)29-62(15,56(70)40(52)10)86-60(72)64-61(13,14)24-25-87(73,74)45-23-21-20-22-43(45)63;2-1-3/h20-23,32-42,47-55,58-59,68-69H,24-31H2,1-19H3,(H,64,72);1H,(H,2,3)/b65-44+;/t33-,34-,35?,36+,37-,38+,39-,40+,41+,42+,47-,48+,49+,50-,51+,52+,53-,54+,55+,58-,59+,62-;/m0./s1
InChIKeyURUFOIQOFMYMDO-HVPQTUPFSA-N
XLogP6.49
TPSA318.57 Ų
H-Bond Donors4
H-Bond Acceptors23
Rotatable Bonds20
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001306.59
LogP ≤ 56.49
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid?
The IUPAC name of [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid (CID 172945734) is [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid.
What is the SMILES notation for [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid?
The canonical SMILES for [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid is CO/N=C1\C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3CC(C)N(C)C[C@H](C)O3)[C@@H](C)C(=O)O[C@H]([C@@H](C)CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@H](C)[C@@H](OC(=O)CC(C)C)[C@@H](C)C(=O)[C@@](C)(OC(=O)NC(C)(C)CCS(=O)(=O)c3ccccc3F)C[C@@H]2C)[C@@H]1O.O=CO.
What is the InChIKey of [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid?
The InChIKey is URUFOIQOFMYMDO-HVPQTUPFSA-N. The full InChI is InChI=1S/C62H102FN3O20S.CH2O2/c1-32(2)26-46(67)82-52-39(9)51(34(4)31-78-59-55(76-18)54(75-17)48(68)42(12)81-59)84-57(71)41(11)53(83-47-27-35(5)66(16)30-37(7)79-47)38(8)50(85-58-49(69)44(65-77-19)28-36(6)80-58)33(3)29-62(15,56(70)40(52)10)86-60(72)64-61(13,14)24-25-87(73,74)45-23-21-20-22-43(45)63;2-1-3/h20-23,32-42,47-55,58-59,68-69H,24-31H2,1-19H3,(H,64,72);1H,(H,2,3)/b65-44+;/t33-,34-,35?,36+,37-,38+,39-,40+,41+,42+,47-,48+,49+,50-,51+,52+,53-,54+,55+,58-,59+,62-;/m0./s1.
What are the key properties of [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid?
[(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid has a molecular weight of 1306.59 g/mol, XLogP of 6.49, 20 rotatable bonds, 4 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-7-[[4-(2-fluorophenyl)sulfonyl-2-methylbutan-2-yl]carbamoyloxy]-2-[(2S)-1-[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxypropan-2-yl]-10-[(2S,3R,4E,6R)-3-hydroxy-4-methoxyimino-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[(2S,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy]-oxacyclotetradec-4-yl] 3-methylbutanoate;formic acid is sourced from PubChem (CID 172945734), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).